Eppen_TracePCR_Dec24
  Editorial
 THE INDIAN PHARMACOPOEIA 2026   
 Wednesday, January 7, 2026 
 On January 2, 2026, the Union Health Ministry has released the Indian Pharmacopoeia 2026 (IP-2026) which is the 10th edition of India’s official book of drug standards, marking a significant milestone in India’s ongoing 
  Past Editorial...  
TODAY'S NEWS
16:15  [IST]Bionpharma gets US FDA nod for etravirine tablets developed in collaboration with STEERLife
16:00  [IST]Boston Scientific enters agreement to acquire medical technology company, Valencia Technologies
15:45  [IST]Sentynl Therapeutics receives US FDA approval of Zycubo to treat paediatric patients with Menkes disease
15:30  [IST]Telangana DCA seizes spurious ‘Levipil 500’ falsely labelled as Sun Pharma product
15:00  [IST]SciNeuro and Novartis ink licensing and collaboration agreement for next generation therapeutics to treat Alzheimer’s disease
14:00  [IST]AbbVie & RemeGen enter exclusive licensing agreement to develop novel bispecific antibody for advanced solid tumours
more news >>
TOP NEWS
08:00  [IST]DoP may exempt 11 more drugs from public procurement rules that restricts global tender
08:00  [IST]Drug authorities across India intensify crackdown on toxic contaminants in paediatric medicines
08:00  [IST]Needle-free drug delivery signals India’s next wave of biologics and biosimilar growth: Sarvesh Mutha
08:00  [IST]ICMR introduces grant scheme to promote development of new technologies of public health importance
08:00  [IST]Indian pharma transitions to biologics & gene therapies amid regulatory & IP constraints
08:00  [IST]DoP calls for proposals to set up common facilities for medical device clusters
more news >>
YESTERDAY'S NEWS
17:30  [IST]IIT Bombay’s TIH concludes ATMAN 3.0; 6 HealthTech startups to get upto Rs. 6 crore cumulative seed funding
17:15  [IST]Jubilant Biosys doubles early chemistry scale-up capacity with new Noida facility in India
15:15  [IST]Health ministry notifies recruitment of 2 more drug inspectors
14:30  [IST]Alembic Pharmaceuticals receives US FDA tentative approval for Bosutinib tablets
14:15  [IST]Aragen unveils CHOMax, an accelerated platform for DNA to IND-enabling clinical supply in 10 months
13:45  [IST]Manipal Hospital Gurugram launches ‘Kawach’, a community-health screening programme
more news >>
INTERVIEW  
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram